(VIANEWS) – SCOR SE (SCR.PA), AXA (CS.PA), SANOFI (SAN.PA) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| SCOR SE (SCR.PA) | 9.54% | 2024-09-01 12:02:23 |
| AXA (CS.PA) | 6.1% | 2024-09-01 07:32:25 |
| SANOFI (SAN.PA) | 3.72% | 2024-09-01 12:02:11 |
| SOPRA STERIA GROUP (SOP.PA) | 2.66% | 2024-09-01 12:02:59 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. SCOR SE (SCR.PA)
9.54% Foward Dividend Yield
SCOR SE’s last close was €18.87, 41.9% below its 52-week high of €32.48. Intraday change was 4.8%.
SCOR SE, together with its subsidiaries, provides life and non-life reinsurance products in Europe, the Middle East, Africa, the Americas, Latin America, and Asia Pacific. It operates in two segments, SCOR P&C and SCOR L&H. The SCOR P&C segment offers reinsurance products in the areas of property, motors, casualty treaties, credit and surety, decennial insurance, aviation, marine and energy, engineering, agricultural risks, and property catastrophes; specialties insurance products, including business solutions, political and credit risks, cyber, and environmental liability; and business ventures and partnerships. The SCOR L&H segment provides life reinsurance products, such as protection for mortality, morbidity, behavioral risks, disability, long-term care, critical illness, medical, and personal accident. This segment also provides financial solutions that combine traditional life reinsurance with financial components and provide liquidity, balance sheet, solvency, and income improvements to clients; longevity solutions that include products covering the risk of negative deviation from expected results due to the insured or annuitant living longer than assumed in the pricing of insurance covers provided by insurers or pension funds; and distribution solutions. In addition, it is involved in the asset management business. SCOR SE was founded in 1970 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SCOR SE has a trailing twelve months EPS of €4.45.
PE Ratio
SCOR SE has a trailing twelve months price to earnings ratio of 7.21. Meaning, the purchaser of the share is investing €7.21 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.91%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 32.1% and positive 28% for the next.
Moving Average
SCOR SE’s value is way higher than its 50-day moving average of €20.88 and way higher than its 200-day moving average of €26.48.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 27, 2024, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 9.54%.
More news about SCOR SE.
2. AXA (CS.PA)
6.1% Foward Dividend Yield
AXA’s last close was €34.40, 2.24% below its 52-week high of €35.19. Intraday change was 0.29%.
AXA SA, through its subsidiaries, provides insurance, asset management, and banking services worldwide. The company operates through six segments: France; Europe; AXA XL; Asia, Africa & EME-LATAM; AXA Investment Managers; and Transversal & Other segments It offers life and savings insurance products, such as savings and retirement, other health, and personal protection products. The company also provides property and casualty insurance products, including car, home, and personal or professional liability to individual and business clients; international insurance for large corporate clients in Europe; and marine and aviation insurance services, as well as property and casualty reinsurance products. In addition, it offers asset management services in the areas of various asset classes, including equities, bonds, hedge funds, private equity, and real estate for the group's insurance companies and their clients, and retail and institutional clients. Further, the company provides motor, household, property and general liability, health, term life, whole life, universal life, endowment, deferred and immediate annuities, and other investment-based products for personal/individual and commercial/ group customers. AXA SA was founded in 1852 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, AXA has a trailing twelve months EPS of €2.88.
PE Ratio
AXA has a trailing twelve months price to earnings ratio of 11.94. Meaning, the purchaser of the share is investing €11.94 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.77%.
Volatility
AXA’s last week, last month’s, and last quarter’s current intraday variation average was 0.33%, 0.34%, and 1.01%.
AXA’s highest amplitude of average volatility was 0.34% (last week), 0.74% (last month), and 1.01% (last quarter).
Volume
Today’s last reported volume for AXA is 702509 which is 81.18% below its average volume of 3734720.
Moving Average
AXA’s value is above its 50-day moving average of €32.05 and higher than its 200-day moving average of €31.29.
More news about AXA.
3. SANOFI (SAN.PA)
3.72% Foward Dividend Yield
SANOFI’s last close was €101.20, 2.99% under its 52-week high of €104.32. Intraday change was -0.87%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
More news about SANOFI.
4. SOPRA STERIA GROUP (SOP.PA)
2.66% Foward Dividend Yield
SOPRA STERIA GROUP’s last close was €174.50, 27.17% under its 52-week high of €239.60. Intraday change was 0.09%.
Sopra Steria Group SA provides consulting, digital, and software development services in France and internationally. It operates through five segments: France, United Kingdom, Other Europe, Sopra Banking Software, and Other Solutions. The company offers digital transformation consulting services; artificial intelligence; technology services in the field of artificial intelligence, blockchain, cloud, data, internet of things, digital interactions, emerging technologies, 5G design center, industrial metaverse, and intelligent process automation; systems integration comprising smart application modernization and product lifecycle management; infrastructure management services, including consulting, cloud, end-user support, digital workplace, and legacy services; and cybersecurity services. It also provides property management solutions; banking solutions, such as software, systems integration, support, and associated consulting services to banks and financial institutions; and HR solutions to public and private sector organizations, as well as acts as a software house, integrator, advisor, and cloud player. In addition, the company offers business process services, such as creation or on-boarding, and operation of multi-function shared services; and operation of finance and administration, and human resource functions, as well as operation of specialized industry-specific business processes comprising operating and executing services in police control rooms, managing compliance in financial services, and managing customer services for large utilities. It serves aerospace, defense and security, energy and utilities, financial services, insurance and social, government, retail, telecommunication, media and entertainment, and transport industries. Sopra Steria Group SA was incorporated in 1968 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SOPRA STERIA GROUP has a trailing twelve months EPS of €8.95.
PE Ratio
SOPRA STERIA GROUP has a trailing twelve months price to earnings ratio of 25.07. Meaning, the purchaser of the share is investing €25.07 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.82%.
Yearly Top and Bottom Value
SOPRA STERIA GROUP’s stock is valued at €224.40 at 07:50 EST, below its 52-week high of €239.60 and way higher than its 52-week low of €150.00.
Moving Average
SOPRA STERIA GROUP’s value is way above its 50-day moving average of €177.18 and way above its 200-day moving average of €203.47.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SOPRA STERIA GROUP’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.2%, now sitting on 6.08B for the twelve trailing months.
More news about SOPRA STERIA GROUP.
